AstraZeneca Appoints Sobi Velauthapillai as Global Marketing Director

AstraZeneca has appointed Sobi Velauthapillai as Global Marketing Director, strengthening its global marketing leadership as the biopharmaceutical company continues to advance innovation and commercial excellence across its portfolio.

In the new role, Sobi will contribute to AstraZeneca's global marketing strategy, supporting initiatives that drive customer engagement, brand growth, and the delivery of innovative healthcare solutions worldwide.

Strengthening Global Marketing Leadership

Announcing the appointment on LinkedIn, Sobi shared the news of joining AstraZeneca as Global Marketing Director and expressed enthusiasm about beginning the next chapter of the professional journey.

The appointment reinforces AstraZeneca's continued investment in experienced marketing leadership to support its global commercial strategy and long-term growth objectives.

Supporting Global Healthcare Innovation

As Global Marketing Director, Sobi will help strengthen AstraZeneca's global marketing efforts, working alongside cross-functional teams to enhance brand strategy, customer engagement, and commercial execution across international markets.

The role comes as pharmaceutical companies continue to invest in digital engagement, data-driven marketing, and patient-centric approaches to accelerate innovation and improve healthcare outcomes.

Looking Ahead

Sobi's appointment reflects AstraZeneca's ongoing focus on building strong global leadership capabilities as it continues delivering innovative medicines and expanding its impact across the healthcare industry.

---

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines across oncology, rare diseases, biopharmaceuticals, and vaccines. Operating in more than 100 countries, the company is committed to advancing healthcare through scientific innovation and research.